







 Opening remarks –
 Dr. Sara Hopkins-Powell 2:00 -2:05
 Case presentation- 2:05-2:30
 Randy Randolph, Physician Assistant 
 Nancy Cicirello, Physical Therapy
 Tiffany Boggis, Occupational Therapy
 Pharmacy
C l i t d t 2 30 3 00 ase ana ys s-s u en s :  – :





W 3 45 4 00 rap up :  – :
P ti t Hi ta en  s ory
 Chief complaint- “Having a hard time 
keeping my balance and seeing”
Patient History- 
History of Present Illness
 58 y.o. white female, presently unemployed, 
uninsured retail worker
 History of Grave’s Disease x one year
 Increasing episodes of dizziness
 Has fallen several times (trouble getting out of tub)        
 No syncope
 Last seen by Endocrinologist 2 months ago,       
medication decreased
 Increasing blurry vision (has trouble reading 
)prescription
P ti t Hi ta en  s ory
 Review of Systems
No history of coronary disease, pulmonary      
disease, CVA, kidney disease or neurological 
disease
Occasional heartburn
Last eye exam-many years ago, no glasses
Post-menopausal
 Family History 
None for Graves’ disease, goiter
P ti t Hi ta en  s ory
 Current Medications
Either Prophylthiouricil or mehtimazole
Aspirin, 160 mg. daily
 Past Surgical History
No prior surgeries  
 Immunization History




P ti t Hi ta en  s ory
 Social History 
Smokes 2 packs of cigarettes per week
Drinks two glasses of wine per week      
Denies illicit or recreational drugs
Single mom 
Uses public transportation
Lists family income as $0    
Lives in small apartment with teen age son in 
Portland
Ph i l Eys ca  xam
 WNWD adult female in NAD, dressed 
appropriately, reasonably well groomed
 VS-
Blood pressure 108/64  
Heart rate – 72 and regular
Respiratory rate 12 and regular  –   
Temperature – 98.4
H i ht/ i ht 61 i h 116 de g we g  –  nc es,  poun s
Ph i l Eys ca  xam
 HEENT-
Ears, nose and throat exam normal
Eyes- No ptosis, lid lag or exopthalmos.  
EOM’s intact, PEERLA.  No visual screen 
done
 Neck
Th id l bl l i dyro  pa pa e, norma  s ze an  
consistency.  Non tender and mobile.
Carotids-3+ bilaterally without bruits   
Ph i l Eys ca  xam
 Lungs
Clear to auscultation and percussion    
 Heart
Normal sinus rhythm  
S1 and S2 normal, no murmurs, rubs, clicks or 
gallops
 Abdomen
N l t do organomega y or en erness
Ph i l Eys ca  xam
 Musculoskeletal
 All groups were bilaterally symmetrical and equal in 
strength
 Neurological
 Alert, awake and oriented times three.  Conversation 
h t t ti lsomew a  angen a
 Cranial nerves intact
Gross peripheral neuro exam intact    
 Cerebellar function intact
Gait-Difficulty with heel to toe, and walking on        
heels/toes














Pregnancy (within 12 months)   
Stress
G ’ Diraves  sease
Cli i l if t ti n ca  man es a ons
“all systems full speed ahead”
Skin-warm and smooth, ↑ sweating, 
hyperpigmentation, hives, hair thinning
Eyes-Stare, lid lag, ptosis, opthamolopathy
CV-↑ Blood pressure, heart rate, pulse pressure, 
ti f il t i l fib ill ticonges ve a ure, a r a  r a on
Pulmonary-Dyspnea, asthma, tracheal obstruction
GI-Weight loss, hyperdefecation, malabsorption
G ’ Diraves  sease
 Clinical manifestations 
GI-Frequency, nocturia, oligomenorrhea, 
infertility, gynecomastia, erectile dysfunction
Neurological-Tremor, proximal muscle weakness, 
episodic paralysis, MD
Psychiatric-Hyperactivity, emotional lability, 
anxiety, inability to concentrate, insomnia
Other-Anemia, osteoporosis/fracture, ↓ lipids and 
cholesterol
Di i /T t tagnos s rea men
 Diagnosis
↓ TSH, ↑ T3 & T4    
 Treatment
Thyroid suppression (Thionamidies)
R di ti I dia oac ve o ne
Surgery
E th lxop a mos
M di ti f G ’ Die ca ons or raves  sease
 Thionamides
 Agents
P lthi il (PTU) ropy ourac  
 Methimazole (Tapazole)
 Efficacy
 Variable cure rate (10 – 95%)
 Predictors of long-term remission
 > 40 yo
 Mild cases
 Smaller goiters 
 Patient adherence




 Prevents deiodination 
of T4 (PTU only)
Farwell AP, Braverman LE.  Thyroid and 
antithyroid drugs.  In Goodman & Gilman’s – The 
Ph l i l B i f Th ti 11th darmaco og ca  as s o  erapeu cs. e .  
Brunton, LL, Lazo JS, Parker KL, eds.  New 
York: McGraw-Hill.  2006.
Ad Eff t f Thi idverse ec s o  onam es
 Common
 Allergic reactions; maculopapular rash
 Leukopenia (WBC < 4000/mm3)
 Arthralgias and fever
 GI upset
 Severe
 Agranulocytosis (WBC < 250/mm3) w/ symptoms
 Hepatotoxicity
 Other auto-immune diseases
V liti ascu s
 Polymyositis
 Lupus-like syndrome
Weetman AP.  Graves’ disease.  New Eng J Med 2000; 343(17): 1236-1248.
C t f M di ti Thos  o  e ca on erapy
 Methimazole 10 mg Tablets
 10 mg po TID  30 mg/day  $60/month
 Propylthiouracil 50 mg Tablets
 100 mg po TID  300 mg/day  $30/month
 http://www.Needymeds.com
